Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance
Pankaj Taneja, Dejan Maglic, Fumitake Kai, Sinan Zhu, Robert D. Kendig, A. Elizabeth, Kazushi Inoue
- ISSN / E-ISSN
- — / —
- DOI
- 10.4137/cmo.s4773 ↗
- Volume · Issue · Pages
- 4 · — · 15-34
- Publisher
- Libertas Academica Ltd.
- Article URL
- https://doi.org/10.4137/cmo.s4773 ↗
- Article details
- Unverified
Publication date (each date has its type and source)
01 Jan 2010
OpenAlex publication date · source: OpenAlex
| Type | Date | Source |
|---|---|---|
| OpenAlex publication date | 01 Jan 2010 | OpenAlex |
Keywords (as given): breast cancer; prognostic factors; estrogen receptor; progesterone receptor; HER2; trastuzumab; Ki-67; TP53 mutation; cyclin D1; cyclin E1; BRCA1/2; p14ARF; vascular endothelial growth factor; endocrine therapy; chemotherapy response
HEC Status at Publication Not the journal's current status
HEC Status at PublicationNot conclusive
Historical status could not be conclusively determined.
- HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
Best available information, not a definitive status: HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
- Journal
- Clinical Medicine Insights: Oncology
- Publication date used
- 01 Jan 2010 (OpenAlex publication date)
- Applicable HEC period
- None recorded for this date
- Category
- —
- Recognition status
- Unknown (NO_PERIOD_FOR_DATE)
- Source
- —
- Verification status
- Not available
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.
